Logo

Inproteo Signs Up Indiana University Business Students to Commercialize Proteomics Device

Jan 14, 2005

NEW YORK, Jan. 14 (GenomeWeb News) - Inproteo and the Indiana University Kelley School of Business have founded a new company, to be run by students and faculty, to help commercialize new proteomics tools.

 

The first product will be an automated sample loader for proteomics research, developed at Eli Lilly and licensed to Inproteo. Shot, a company based in Greenville, Ind., will develop a prototype, which the new company, to be housed at the Indiana University Research Park in Bloomington, expects to bring to market later this year.

 

Inproteo is a consortium between Eli Lilly, IndianaUniversity, and PurdueUniversitythat aims to license new proteomics technologies or spin them off into new companies.

Breaking News
The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.